Valencia, Spain

José Enrique De La Rubia Orti

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: José Enrique De La Rubia Orti: Innovator in Motor Neuron Disease Treatment

Introduction

José Enrique De La Rubia Orti, an innovative inventor based in Valencia, Spain, has made significant contributions to the field of medical research, particularly in the treatment of motor neuron diseases. With a focus on developing effective therapies, he has secured a patent that reflects his commitment to improving patient outcomes.

Latest Patents

De La Rubia Orti holds a patent for methods and compositions related to treating motor neuron diseases, including Amyotrophic Lateral Sclerosis (ALS). His invention revolves around the use of nicotinamide riboside and pterostilbene for treating and preventing such diseases. The patent outlines the administration of these compounds to subjects, highlighting an oral delivery method as a viable treatment option.

Career Highlights

Throughout his career, José has been associated with reputable institutions such as the Universitat De València Estudi General and Fundación Universidad Católica De Valencia San Vicente Mártir. His work in these institutions demonstrates his dedication to advancing research and innovation in the medical field.

Collaborations

José has collaborated with notable coworkers, including José Maria Estrela Ariguel and Ryan Dellinger. These partnerships underscore the collaborative spirit in the scientific community, paving the way for advancements in treatment strategies for complex diseases.

Conclusion

José Enrique De La Rubia Orti stands out as a notable inventor whose contributions to the treatment of motor neuron diseases have the potential to influence future research and clinical practices. His innovative approaches and dedication to collaboration represent a significant step forward in the fight against ALS and similar conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…